Evidence map›Paper›PMID 22622641›Full record

ReviewNature reviews. Cancer2012

Spatial regulation of receptor tyrosine kinases in development and cancer.

Jessica B Casaletto, Andrea I McClatchey

Abstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 364 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jessica B CasalettoMGH Center for Cancer Research, Charlestown, MA 02129, USA.
Andrea I McClatchey
Harvard University · US

Funding

Molecular Function of the Nf2 Tumor Suppressor, MerlinR01CA113733 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MCCLATCHEY, ANDREA I · 2005 to 2014
$3.1M
NCI NIH HHS R01 CA113733
6 · The paper itself

Abstract

During development and tissue homeostasis, patterns of cellular organization, proliferation and movement are highly choreographed. Receptor tyrosine kinases (RTKs) have a crucial role in establishing these patterns. Individual cells and tissues exhibit tight spatial control of the RTKs that they express, enabling tissue morphogenesis and function, while preventing unwarranted cell division and migration that can contribute to tumorigenesis. Indeed, RTKs are deregulated in most human cancers and are a major focus of targeted therapeutics. A growing appreciation of the essential role of spatial RTK regulation during development prompts the realization that spatial deregulation of RTKs is likely to contribute broadly to cancer development and may affect the sensitivity and resistance of cancer to pharmacological RTK inhibitors.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedCell MembraneCetuximabDrug DesignGene Expression Regulation, EnzymologicHumansMorphogenesisNeoplasmsReceptor Protein-Tyrosine KinasesSignal TransductionTumor MicroenvironmentAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedCetuximabReceptor Protein-Tyrosine Kinases

Identifiers

PMID22622641
PMCPMC3767127
OpenAlexW2085365699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.